Reuters logo
3 个月前
BRIEF-Cytori Therapeutics completes follow up monitoring visits in FDA approved late-stage STAR trial
2017年5月23日 / 下午12点52分 / 3 个月前

BRIEF-Cytori Therapeutics completes follow up monitoring visits in FDA approved late-stage STAR trial

May 23 (Reuters) - Cytori Therapeutics Inc-

* Cytori Therapeutics Inc - now completed all 48 week follow up monitoring visits in its U.S. FDA approved phase III star trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below